Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-30

Clinical Trial Update: Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI [Phase 4]

View source ↗

Summary

This Phase 4 trial update assesses remifentanil and laryngeal reflex responses in pediatric patients with upper respiratory infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)

Snippet

Sponsor: Thomas Erb | Conditions: Upper Respiratory Infections | Phase 4 | Status: COMPLETED